https://www.massgeneral.org/news/research-spotlight/sars-cov-2-vaccine-delayed-localizing-necrotizing-myositis
0
0
Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis after SARS-CoV-2 mRNA-1273 (“Moderna”) Vaccine: A Case Report. - Massachusetts General Hospital
10/11/22 at 3:35pm
Organization
Massgeneral.org
47 words
0
Comments
Clinicians describe the presentation and successful treatment of delayed localized necrotizing inflammatory myositis following the third dose of the mRNA-1273 SARS-CoV-2 vaccine.
You are the first to view
Create an account or login to join the discussion